Know Cancer

or
forgot password

registHER: An Observational Cohort Study of Patients With HER2 Positive Metastatic Breast Cancer


Phase 4
N/A
N/A
Not Enrolling
Both
Breast Cancer

Thank you

Trial Information

registHER: An Observational Cohort Study of Patients With HER2 Positive Metastatic Breast Cancer


Inclusion Criteria:



- Signed Informed Consent document (unless the IRB has granted a waiver of consent)

- Signed Authorization for the Use and Disclosure of Health Information document

- HER2-positive breast cancer

- Initial diagnosis of metastatic (Stage IV) breast cancer within 6 months prior to
enrollment

- Availability of cancer-specific historical data points in the patient's medical
records

Exclusion Criteria:

- There are no exclusion criteria for participation in this trial

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Isaiah Dimery, M.D.

Investigator Role:

Study Director

Investigator Affiliation:

Genentech

Authority:

United States: Institutional Review Board

Study ID:

H2757n

NCT ID:

NCT00105456

Start Date:

March 2003

Completion Date:

May 2009

Related Keywords:

  • Breast Cancer
  • HER2-Positive Metastatic Breast Cancer
  • HER2
  • Breast Neoplasms

Name

Location